CANADIAN CHILDREN INFLAMMATORY BOWEL DISEASE NETWORK:
A Joint Partnership of the CH.I.L.D. Foundation and the Canadian Institute of Health Research
The Canadian Children Inflammatory Bowel Disease Network: A Joint Partnership of the CH.I.L.D. Foundation and the Canadian Institute of Health Research has commenced its operations. The network leadership has submitted their response to the issues identified by the International Peer Review Panel in the spring of 2013 and that response has been reviewed favourably by the same international peer review panel members on September 26, 2013.
A Network Advisory Committee has been established to guide the network’s start-up and growth phase and offer advice on the most efficient and effective governance and leadership mechanisms for the network to use. The role of the Advisory Committee is to provide advice to the network leadership team and the funder organizations (the CH.I.L.D. Foundation and CIHR-INMD) on the required strategies, structures, and processes to further the network’s achievement of its strategic goals.
CCIBD Network Advisory Committee
Together with representatives from the CH.I.L.D. Foundation and CIHR. the inaugural meeting of the Network Advisory Committee will be held in Vancouver on October 19, 2013. The CH.I.L.D. Foundation is most appreciative of the Advisory Committee’s volunteer assistance and guidance.
Cathleen Morrison, Chair. Cathleen’s life work has been rooted in the charitable and voluntary sector. Cathleen led Cystic Fibrosis Canada for thirty years as Chief Executive Officer, during a time of remarkable growth and change, until her retirement in 2011. She is a member of the Board of Directors of Friends of Canadian Institutes of Health Research, and an Honourary Life Member of Research Canada – An Alliance for Health Discovery, having served as a Board member of the Canadian Bacterial Diseases Network, and as Chair of the National Voluntary Health Agencies Committee.
Neelu Chauhan, BSc, LLB, is a Labour Relations Consultant at British Columbia Institute of Technology, providing labour relations advice, service and support to management regarding the interpretation, administration and application of collective agreements in multi-union, public sector environments. An advocate for patients with Crohn’s Disease and Ulcerative Colitis, she has been a Member, Research Ethics Board, BCIT, and Member, Editorial Advisory Committee, Peopletalk Magazine, relating to wellness in the workplace.
Brett Finlay, OC, OBC, PhD, is a Professor in the Michael Smith Laboratories, and the Departments of Biochemistry and Molecular Biology, and Microbiology and Immunology at the University of British Columbia. By combining cell biology with microbiology, he has been at the forefront of the emerging field called Cellular Microbiology, making several fundamental discoveries in this field. He is well recognized internationally for his work, particularly as Director, SARS Accelerated Vaccine Initiative. He serves on several editorial and advisory boards, including the CH.I.L.D. Foundation Scientific Research Advisory Council, and is a strong supporter of communicating science to the public.
Claudio Fiocchi, MD, is a senior researcher in the department of pathobiology of Lerner Research Institute of Cleveland Clinic. He is also the Director of IBD and Vice Chairman of Research for the Department of Gastroenterology and Hepatology in the Digestive Disease Institute of Cleveland Clinic. His many awards include the Crohn’s and Colitis Foundation of America’s Janowitz Lifetime Achievement Award in Inflammatory Bowel Disease.
Peter Margolis, MD, PhD, is Professor, Pediatrics and Director of Research at the James M. Anderson Center for Health System Excellence at Cincinnati Children’s Hospital Medical Center. His work encompasses the application and study of quality improvement methods in a broad range of areas including primary and sub-specialty care, communities and public health settings to improve the health outcomes of children, families and communities. He is principal investigator on an NIH Roadmap transformative research grant on redesigning systems for chronic illness care.